Biomarkers of functional class in systolic heart failure: The relevance of copeptin

1991, Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators, N Engl J Med, 325, 293, 10.1056/NEJM199108013250501 Pitt, 1999, The effect of spironolactone on morbidity and mortality in patients with severe heart failure Randomized Aldactone Evaluation Study Investigators, N Engl J Med, 341, 709, 10.1056/NEJM199909023411001 1999, The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial, Lancet, 353, 9, 10.1016/S0140-6736(98)11181-9 Rivero-Ayerza, 2006, Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials, Eur Heart J, 27, 2682, 10.1093/eurheartj/ehl203 Ahmed, 2006, Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function, Am Heart J, 151, 444, 10.1016/j.ahj.2005.03.066 Doval, 1996, Nonsustained ventricular tachycardia in severe heart failure, Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators, Circulation, 94, 3198, 10.1161/01.CIR.94.12.3198 Francis, 1995, Open access echocardiography in management of heart failure in the community, BMJ, 310, 634, 10.1136/bmj.310.6980.634 Mosterd, 1999, Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study, Eur Heart J, 20, 447, 10.1053/euhj.1998.1239 Pfeffer, 1992, Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators, N Engl J Med, 327, 669, 10.1056/NEJM199209033271001 Vanoverschelde, 1990, Left ventricular filling in dilated cardiomyopathy: relation to functional class and hemodynamics, J Am Coll Cardiol, 15, 1288, 10.1016/S0735-1097(10)80016-6 Pinamonti, 1993, Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and hemodynamic correlations and prognostic implications. Heart Muscle Disease Study Group, J Am Coll Cardiol, 22, 808, 10.1016/0735-1097(93)90195-7 Nagueh, 1997, Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures, J Am Coll Cardiol, 30, 1527, 10.1016/S0735-1097(97)00344-6 Devereux, 1986, Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings, Am J Cardiol, 57, 450, 10.1016/0002-9149(86)90771-X Lang, 2005, J Am Soc Echocardiogr, 18, 1440, 10.1016/j.echo.2005.10.005 Requarth, 1984, In vitro verification of Doppler prediction of transvalve pressure gradient and orifice area in stenosis, Am J Cardiol, 53, 1369, 10.1016/0002-9149(84)90096-1 Madsen, 1994, Chronic congestive heart failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms, Eur Heart J, 15, 303, 10.1093/oxfordjournals.eurheartj.a060495 Bouvy, 2003, Predicting mortality in patients with heart failure: a pragmatic approach, Heart, 89, 605, 10.1136/heart.89.6.605 Jiang, 2001, Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure, Arch Intern Med, 161, 1849, 10.1001/archinte.161.15.1849 Muntwyler, 2002, One-year mortality among unselected outpatients with heart failure, Eur Heart J, 23, 1861, 10.1053/euhj.2002.3282 Jones, 2004, Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial, J Am Coll Cardiol, 44, 1025, 10.1016/j.jacc.2004.05.077 Goldman, 1981, Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale, Circulation, 64, 1227, 10.1161/01.CIR.64.6.1227 Ekman, 2005, Symptoms in patients with heart failure are prognostic predictors: insights from COMET, J Card Fail, 11, 288, 10.1016/j.cardfail.2005.03.007 Holland, 2010, Patients’ self-assessed functional status in heart failure by New York Heart Association class: a prognostic predictor of hospitalizations, quality of life and death, J Card Fail, 16, 150, 10.1016/j.cardfail.2009.08.010 Neuhold, 2008, Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease, J Am Coll Cardiol, 52, 266, 10.1016/j.jacc.2008.03.050 Dickstein, 2008, Eur Heart J, 29, 2388, 10.1093/eurheartj/ehn309 Omland, 2002, N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes, Circulation, 106, 2913, 10.1161/01.CIR.0000041661.63285.AE Maisel, 2002, Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure, N Engl J Med, 347, 161, 10.1056/NEJMoa020233 Hobbs, 2002, Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations, BMJ, 324, 1498, 10.1136/bmj.324.7352.1498 Wang, 2004, Plasma natriuretic peptide levels and the risk of cardiovascular events and death, N Engl J Med, 350, 655, 10.1056/NEJMoa031994 Kalra, 2001, Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin, Cardiovasc Res, 51, 495, 10.1016/S0008-6363(01)00297-8 Kanu, 2005, Neurohormonal activation in congestive heart failure and the role of vasopressin, Am J Cardiol, 95, 8, 10.1016/j.amjcard.2005.03.003 Francis, 1990, Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD), Circulation, 82, 1724, 10.1161/01.CIR.82.5.1724 Rouleau, 1994, Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril, J Am Coll Cardiol, 24, 583, 10.1016/0735-1097(94)90001-9 Nakamura, 2006, Possible vascular role of increased plasma arginine vasopressin in congestive heart failure, Int J Cardiol, 106, 191, 10.1016/j.ijcard.2005.01.043 Struck, 2005, Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients, Peptides, 26, 2500, 10.1016/j.peptides.2005.04.019 Konstam, 2007, Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial, JAMA, 297, 1319, 10.1001/jama.297.12.1319 Gheorghiade, 2007, Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials, JAMA, 297, 1332, 10.1001/jama.297.12.1332 Rodondi, 2005, Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death, Arch Intern Med, 165, 2460, 10.1001/archinte.165.21.2460 Cromie, 2002, Anaemia in chronic heart failure: what is its frequency in the UK and its underlying causes?, Heart, 87, 377, 10.1136/heart.87.4.377 Lipkin, 1986, Factors determining symptoms in heart failure: comparison of fast and slow exercise tests, Br Heart J, 55, 439, 10.1136/hrt.55.5.439 Clark, 1996, Exercise limitation in chronic heart failure: central role of the periphery, J Am Coll Cardiol, 28, 1092, 10.1016/S0735-1097(96)00323-3 Wilson, 1993, Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure, Circulation, 87, 470, 10.1161/01.CIR.87.2.470 Zannad, 2010, Eplerenone in patients with systolic heart failure and mild symptoms, N Engl J Med Pitt, 1999, The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators, N Engl J Med, 341, 709, 10.1056/NEJM199909023411001 Rihal, 1994, Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis, Circulation, 90, 2772, 10.1161/01.CIR.90.6.2772 Naeije, 1994, Nature of pulmonary hypertension in congestive heart failure. Effects of cardiac transplantation, Am J Respir Crit Care Med, 149, 881, 10.1164/ajrccm.149.4.8143050 Chakko, 1991, Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care, Am J Med, 90, 353, 10.1016/0002-9343(91)90576-J Badgett, 1997, Can the clinical examination diagnose left-sided heart failure in adults?, JAMA, 277, 1712, 10.1001/jama.1997.03540450068038 Buller, 1991, Direct measurement of skeletal muscle fatigue in patients with chronic heart failure, Br Heart J, 65, 20, 10.1136/hrt.65.1.20 Mancini, 1992, Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure, Circulation, 85, 1364, 10.1161/01.CIR.85.4.1364 Clini, 2000, Endogenous nitric oxide in patients with chronic heart failure (CHF): relation to functional impairment and nitrate-containing therapies, Int J Cardiol, 73, 123, 10.1016/S0167-5273(00)00211-4 Clark, 1995, Anatomical dead space, ventilatory pattern, and exercise capacity in chronic heart failure, Br Heart J, 74, 377, 10.1136/hrt.74.4.377 Galie, 2009, Eur Heart J, 30, 2493, 10.1093/eurheartj/ehp297 Delgado, 2005, Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure, Eur J Heart Fail, 7, 1011, 10.1016/j.ejheart.2004.10.021 Abramson, 1992, Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy, Ann Intern Med, 116, 888, 10.7326/0003-4819-116-11-888 Butler, 1999, Pulmonary hypertension and exercise intolerance in patients with heart failure, J Am Coll Cardiol, 34, 1802, 10.1016/S0735-1097(99)00408-8 Di Salvo, 1995, Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure, J Am Coll Cardiol, 25, 1143, 10.1016/0735-1097(94)00511-N Arena, 2007, Development of a ventilatory classification system in patients with heart failure, Circulation, 115, 2410, 10.1161/CIRCULATIONAHA.107.686576 Lewis, 2008, Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone, Circ Heart Fail, 1, 227, 10.1161/CIRCHEARTFAILURE.108.785501 Grigioni, 2006, Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure, J Heart Lung Transplant, 25, 1241, 10.1016/j.healun.2006.06.015 Lewis, 2007, Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension, Circulation, 116, 1555, 10.1161/CIRCULATIONAHA.107.716373 Gottdiener, 2000, Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study, J Am Coll Cardiol, 35, 1628, 10.1016/S0735-1097(00)00582-9 Sarnak, 2005, Cystatin C concentration as a risk factor for heart failure in older adults, Ann Intern Med, 142, 497, 10.7326/0003-4819-142-7-200504050-00008 Shlipak, 2006, Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease, Ann Intern Med, 145, 237, 10.7326/0003-4819-145-4-200608150-00003 Shlipak, 2003, Pharmacotherapy for heart failure in patients with renal insufficiency, Ann Intern Med, 138, 917, 10.7326/0003-4819-138-11-200306030-00013 Shlipak, 2004, The clinical challenge of cardiorenal syndrome, Circulation, 110, 1514, 10.1161/01.CIR.0000143547.55093.17 Shlipak, 2011, Symptoms characteristic of heart failure among CKD patients without diagnosed heart failure, J Card Fail, 17, 17, 10.1016/j.cardfail.2010.08.009